Reply to Joep J. de Jong and Ewan A. Gibb's Letter to the Editor re: Gottfrid Sjödahl, Johan Abrahamsson, Karin Holmsten, et al. Different Responses to Neoadjuvant Chemotherapy in Urothelial Carcinoma Molecular Subtypes. Eur Urol. 2022;81:316-7. Neoadjuvant Chemotherapy Response in Muscle-invasive Bladder Cancer: Differences in Intrinsic Biology or Subtyping Nomenclature?

Affiliations

¹ Department of Translational Medicine, Lund University, Malmö, Sweden; Department of Urology, Skåne University Hospital, Malmö, Sweden. Electronic address: gottfrid.sjodahl@med.lu.se.
² Department of Translational Medicine, Lund University, Malmö, Sweden; Department of Urology, Skåne University Hospital, Malmö, Sweden.
³ Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden; Department of Oncology, Capio S:t Göran Hospital, Stockholm, Sweden.
⁴ Division of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden.
⁵ Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden; Department of Pelvic Cancer, Genitourinary Oncology and Urology Unit, Karolinska University Hospital, Stockholm, Sweden.

Comment

Gottfrid Sjödahl et al. Eur Urol. 2022 Apr.

. 2022 Apr;81(4):e92-e93.

doi: 10.1016/j.eururo.2021.12.035. Epub 2022 Jan 14.

¹ Department of Translational Medicine, Lund University, Malmö, Sweden; Department of Urology, Skåne University Hospital, Malmö, Sweden. Electronic address: gottfrid.sjodahl@med.lu.se.
² Department of Translational Medicine, Lund University, Malmö, Sweden; Department of Urology, Skåne University Hospital, Malmö, Sweden.
³ Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden; Department of Oncology, Capio S:t Göran Hospital, Stockholm, Sweden.
⁴ Division of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden.
⁵ Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden; Department of Pelvic Cancer, Genitourinary Oncology and Urology Unit, Karolinska University Hospital, Stockholm, Sweden.

No abstract available

Comment on

Different Responses to Neoadjuvant Chemotherapy in Urothelial Carcinoma Molecular Subtypes.
Sjödahl G, Abrahamsson J, Holmsten K, Bernardo C, Chebil G, Eriksson P, Johansson I, Kollberg P, Lindh C, Lövgren K, Marzouka NA, Olsson H, Höglund M, Ullén A, Liedberg F. Sjödahl G, et al. Eur Urol. 2022 May;81(5):523-532. doi: 10.1016/j.eururo.2021.10.035. Epub 2021 Nov 13. Eur Urol. 2022. PMID: 34782206
Re: Gottfrid Sjödahl, Johan Abrahamsson, Karin Holmsten, et al. Different Responses to Neoadjuvant Chemotherapy in Urothelial Carcinoma Molecular Subtypes. Eur Urol. 2022;81:316-7.: Neoadjuvant Chemotherapy Response in Muscle-invasive Bladder Cancer: Differences in Intrinsic Biology or Subtyping Nomenclature?
de Jong JJ, Gibb EA. de Jong JJ, et al. Eur Urol. 2022 Apr;81(4):e90-e91. doi: 10.1016/j.eururo.2021.12.033. Epub 2022 Jan 14. Eur Urol. 2022. PMID: 35034800 No abstract available.